What are the guidelines for normal, impaired, and diabetic fasting blood sugar levels?

Fasting Blood Sugar Guidelines

Fasting plasma glucose ≥126 mg/dL (7.0 mmol/L) is diagnostic for diabetes, impaired fasting glucose is 100-125 mg/dL (5.6-6.9 mmol/L), and normal fasting glucose is <100 mg/dL (5.6 mmol/L), with all abnormal results requiring confirmation by repeat testing on a separate day. 1

Normal Fasting Blood Glucose

• Normal fasting plasma glucose is defined as <100 mg/dL (5.6 mmol/L) according to both the American Diabetes Association and European Society of Cardiology guidelines 1
• For adults without diabetes, optimal fasting blood glucose ranges from 70-99 mg/dL (3.9-5.5 mmol/L) 2
• The normal reference interval for laboratory measurements is 4.1-6.1 mmol/L (74-110 mg/dL) for adults 3

Impaired Fasting Glucose (Prediabetes)

• Impaired fasting glucose is defined as fasting plasma glucose between 100-125 mg/dL (5.6-6.9 mmol/L) per American Diabetes Association criteria 1, 4
• The WHO uses a slightly different threshold, defining impaired fasting glucose as 6.1-6.9 mmol/L (110-125 mg/dL) 1
• This intermediate category affects approximately 1 in 3 adults in the United States and represents increased risk for progression to diabetes 4
• Approximately 10% of people with prediabetes progress to diabetes each year 4

Diabetes Diagnosis

• Fasting plasma glucose ≥126 mg/dL (7.0 mmol/L) meets the diagnostic threshold for diabetes mellitus 1
• This diagnosis must be confirmed by repeat testing on a different day in the absence of unequivocal hyperglycemia 1, 5
• Random plasma glucose ≥200 mg/dL (11.1 mmol/L) with classic symptoms (polyuria, polydipsia, weight loss) is also diagnostic 1
• HbA1c ≥6.5% provides an alternative diagnostic criterion when performed in a certified laboratory 1

Critical Testing Requirements

• Blood must be drawn after at least 8 hours of fasting, preferably in the morning 1
• Samples should be collected in tubes containing rapidly effective glycolytic inhibitors such as citrate buffer to prevent falsely low results 1, 3
• If proper collection tubes are unavailable, samples must be placed immediately in ice-water slurry and centrifuged within 15-30 minutes 1, 3
• Testing must be performed in an accredited laboratory using venous plasma, not capillary blood or point-of-care meters, for diagnostic purposes 1, 3

Confirmation of Abnormal Results

• Any single abnormal fasting glucose result must be confirmed by repeat testing on a separate day unless the patient presents with unequivocal hyperglycemia or hyperglycemic crisis 1, 5
• When fasting glucose and HbA1c results are discordant (one meeting diabetes criteria, one not), repeat the abnormal test within 3-6 months to establish the diagnosis 5
• If repeat fasting glucose is ≥126 mg/dL (7.0 mmol/L), diagnose diabetes even if HbA1c is <6.5% 5

Common Pitfalls to Avoid

• Do not use point-of-care glucose meters for diagnostic purposes as they lack the precision required and are not validated for diagnosis 2
• Avoid tubes containing only sodium fluoride as an enolase inhibitor, as these do not adequately prevent glycolysis 1
• Do not interpret a single borderline result as definitive; biological variation can cause fasting glucose to fluctuate 4.8-7.1% within the same person 3, 2
• Do not confuse normal reference ranges with diagnostic criteria for diabetes—these are different thresholds 3
• Recognize that stress, acute illness, and certain medications (especially glucocorticoids) can transiently elevate glucose levels 2

Risk Stratification Within Normal Range

• Even within the "normal" range, higher fasting glucose levels (87-99 mg/dL) independently predict future diabetes risk compared to lower normal levels (<81 mg/dL) 6
• The combination of fasting glucose 91-99 mg/dL with triglycerides ≥150 mg/dL increases diabetes risk 8-fold compared to lower values 6
• First-degree relatives of people with type 2 diabetes show 31% frequency of impaired fasting glucose, warranting earlier screening 7